Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin (pin regimen)in patients with urothelial cancer who have received prior cisplatin-based therapy

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2005年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [1] Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who have received prior cisplatin-based therapy
    Shinohara, N
    Suzuki, S
    Abe, T
    Sazawa, A
    Harabayashi, T
    Nonomura, K
    JOURNAL OF UROLOGY, 2005, 173 (04): : 358 - 358
  • [2] Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy
    Shinohara, Nobuo
    Harabayashi, Toru
    Suzuki, Shin
    Nagao, Kazuhiro
    Seki, Haruo
    Murakumo, Masashi
    Mitsuhashi, Kimiyoshi
    Demura, Takayoshi
    Nagamori, Satoshi
    Matsuyama, Hideyasu
    Naito, Katsusuke
    Nonomura, Katsuya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (03) : 402 - 407
  • [3] Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy
    Nobuo Shinohara
    Toru Harabayashi
    Shin Suzuki
    Kazuhiro Nagao
    Haruo Seki
    Masashi Murakumo
    Kimiyoshi Mitsuhashi
    Takayoshi Demura
    Satoshi Nagamori
    Hideyasu Matsuyama
    Katsusuke Naito
    Katsuya Nonomura
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 402 - 407
  • [4] Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy.
    Shinohara, N.
    Harabayashi, T.
    Suzuki, S.
    Nagao, K.
    Nagamori, S.
    Matsuyama, H.
    Naito, K.
    Nonomura, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 236S - 236S
  • [5] Combination chemotherapy with paclitaxel, ifoseamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy: Advanced report
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 291 - 291
  • [6] Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy
    Kanai, Kunimitsu
    Kikuchi, Eiji
    Ohigashi, Takashi
    Miyajima, Akira
    Nakagawa, Ken
    Nakashima, Jun
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (06) : 510 - 514
  • [7] Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy
    Kunimitsu Kanai
    Eiji Kikuchi
    Takashi Ohigashi
    Akira Miyajima
    Ken Nakagawa
    Jun Nakashima
    Mototsugu Oya
    International Journal of Clinical Oncology, 2008, 13 : 510 - 514
  • [8] Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy
    Sternberg, CN
    Calabrò, F
    Pizzocaro, G
    Marini, L
    Schnetzer, S
    Sella, A
    CANCER, 2001, 92 (12) : 2993 - 2998
  • [9] Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy
    Kobayashi, Keita
    Matsuyama, Hideyasu
    Shimizu, Kosuke
    Fujii, Nakanori
    Inoue, Ryo
    Yamamoto, Yoshiaki
    Matsumoto, Hiroaki
    Nagao, Kazuhiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (08) : 775 - 780
  • [10] Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen
    Takahashi, T
    Higashi, S
    Nishiyama, H
    Segawa, T
    Nakamura, E
    Kinoshita, H
    Itoh, N
    Yamamoto, S
    Kamoto, T
    Habuchi, T
    Ogawa, O
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (02) : 104 - 108
12345